Cargando…
Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids
BACKGROUND: Because Plasmodium falciparum displays increase tolerance against the recommended artemisinin combination therapies (ACT), new classes of anti-malarial drugs are urgently required. Previously synthesized artemisinin-aminoquinoline hybrids were evaluated to ascertain whether the potent lo...
Autores principales: | Lombard, Marli C, N’Da, David D, Tran Van Ba, Christophe, Wein, Sharon, Norman, Jennifer, Wiesner, Lubbe, Vial, Henri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598976/ https://www.ncbi.nlm.nih.gov/pubmed/23433124 http://dx.doi.org/10.1186/1475-2875-12-71 |
Ejemplares similares
-
Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether
por: Watson, Daniel J., et al.
Publicado: (2021) -
Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model
por: Dambuza, Ntokozo S., et al.
Publicado: (2015) -
Artemisinin anti-malarial drugs in China
por: Guo, Zongru
Publicado: (2016) -
(Iso)Quinoline–Artemisinin Hybrids Prepared through Click Chemistry: Highly Potent Agents against Viruses
por: Çapcı, Aysun, et al.
Publicado: (2020) -
Synergistic anti-malarial action of cryptolepine and artemisinins
por: Forkuo, Arnold D., et al.
Publicado: (2016)